Investors flag UNH and Visa as overvalued on social
- Value-investing posts contrasted intrinsic value with price multiples and flagged names like UnitedHealth at roughly 30x P/E as potentially overvalued on social this week. - Authors argued for Buffett-style focus on durable economics and margin of safety, recommending avoidance of high P/E stocks such as Visa in portfolios. - Threads recommended using discounted cash-flow models and intrinsic-value calculations for stock selection, the posts said. (x.com/NickNorris4933)
1/ Investors on X are calling out UnitedHealth Group (UNH) and Visa (V) as overvalued this week, pushing classic value investing principles amid high P/E ratios. Posts highlight UNH trading at ~30x forward earnings and Visa at ~35x, arguing these multiples exceed intrinsic worth. 2/ The core argument: Price multiples like P/E don't tell the full story—focus on intrinsic value via discounted cash flow (DCF) models, per multiple threads. Users contrast current prices with estimated fair values, often 20-40% below market. Buffett-style "margin of safety" is the mantra: buy only when price << intrinsic value. 3/ UNH specifics: At $580/share (May 17 close), forward P/E sits at 29.5x on $19.70 EPS est. for 2026, per Yahoo Finance. Posters flag Medicare pressures and regulatory risks eroding "durable economics"—UNH's moat from scale in health insurance. One thread values UNH at $420/share using 8% discount rate on projected FCF. 4/ Visa details: $320/share close with 34.8x forward P/E on $9.20 EPS forecast. Critics point to slowing transaction growth (Q1 2026 payments up just 9% YoY) and competition from fintechs like Block or Adyen. DCF calcs in posts peg fair value ~$240, citing peak margins already baked in. 5/ Why Buffett-style? Posters invoke Berkshire Hathaway letters: Seek businesses with predictable cash flows, high ROIC (>15%), and buy at 50%+ discounts to intrinsic value. High P/E names like these lack that cushion—e.g., UNH's 22x P/E avg. over 10yrs vs. today's 30x. Avoid "growth traps" trading on hype. 6/ Tools recommended: Build DCF with 5-10yr FCF projections, terminal value at 3-5% growth, 8-10% WACC. Free resources like GuruFocus or Excel templates shared. One user: "Plug in UNH's numbers—output says sell." Cross-check with normalized earnings to strip one-offs. 7/ Counterpoints in threads: Growth bulls note UNH's 15% EPS CAGR past decade and Visa's network effects (70%+ margins). But value crowd retorts: "Past growth ≠ future; multiples imply perfection." Social sentiment tilts bearish on these—UNH down 2% this week on X buzz. 8/ Broader context: Value investing revival? Amid 2026 market highs (S&P 500 P/E ~24x), these posts echo 2022 bear market calls. Funds like Berkshire hold neither UNH nor Visa heavily (0% stakes per 13F). Watch Q2 earnings: UNH July 16, Visa July 23. 9/ Key takeaway for portfolios: Trim high P/E conviction names; hunt 10-15x P/FCF bargains with strong moats. Threads link to screeners flagging them. Debate rages, but math drives the flags.
